Should You Sell Your Stake in RAPT Therapeutics (RAPT)?

Yahoo FinanceJun 21 01:13 ET

Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround

Yahoo FinanceJun 14 09:35 ET

12 Health Care Stocks Moving In Monday's After-Market Session

GainersFibroGen (NASDAQ:FGEN) stock moved upwards by 24.4% to $1.53 during Monday's after-market session. The market value of their outstanding shares is at $152.1 million. Candel Therapeutics (NASDAQ

BenzingaJun 3 16:31 ET

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u

BenzingaMay 21 08:39 ET

Wolfe Downgrades RAPT, but Still Sees "Immense" Upside Potential

Seeking AlphaMay 14 15:06 ET

Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform

RAPT Therapeutics (RAPT) has an average rating of outperform and price targets ranging from $4 to $33, according to analysts polled by Capital IQ.

MT NewswiresMay 14 07:08 ET